US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.69

-0.4365-1.24%

Post-market: 34.710.0207+0.06%19:30 EDT

Volume:25.49K

Turnover:885.29K

Market Cap:96.44M

PE:- -

High:35.13

Open:35.13

Low:34.63

Close:35.13

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:1.14

T/O Rate:0.92%

Dividend:0.26

Dividend Rate:0.74%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sichuan Biokin's Subsidiary to Invest $5 Million in Oncology Drug Developer Connexus Therapeutics

Fed Rate Decision Finalized, A-Share Market Sees Light Volume Retreat, Grain and Innovative Drug Sectors Gain Momentum | 3A Daily Briefing (September 17, 2026)

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

ETF Market Wrap (09.17) - Fed Hawkish Stance Weighs on Sentiment; AI Drug Development Bolsters Pharma Gains

Big Pharma's AI Push Triggers Rally Across A-Shares and CRO Sector

Mid-Year Drug Sector Report Shows Growing Momentum, Analysts Back Innovative Therapies and Supply Chain Players

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS

Shanghai Raas Advances SR604 Injection Into Phase III Clinical Trial for Hemophilia Prevention

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

CSPC Pharma Initiates Phase II Clinical Trial of SYH2069 Injection for Type 2 Diabetes at First Chinese Study Center

Beijing Sun-Novo Secures Clinical Trial Approval for Heart Failure Treatment Candidate BTP0427

ST Bailing's Subsidiary Receives Clinical Trial Approval for Tangning Tongluo Cream

Hong Kong Stock Market Update: Hengrui Pharma Surges Nearly 4% in Late Trading Following Dual Clinical Trial Approvals

Hong Kong Policy Address: Northern Metropolis Accelerates with Mainland Partnerships and Clinical Trial Hub Launch

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/IBBQ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.6893,"timestamp":1789761600000,"preClose":35.1258,"halted":0,"volume":25488,"hourTrading":{"tag":"盘后","latestPrice":34.71,"preClose":34.6893,"latestTime":"19:30 EDT","volume":16,"amount":555.1565,"timestamp":1789774205753,"change":0.0207,"changeRate":0.000597,"amplitude":0},"delay":0,"changeRate":-0.012426763233862154,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Market Closed","change":-0.4365,"latestTime":"09-18 16:00:00 EDT","open":35.13,"high":35.13,"low":34.6296,"amount":885294.380736,"amplitude":0.014246,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":35.1258,"sharesOutstanding":2520001,"nav":35.11978,"aum":96412871.83,"dividendRate":0.007406,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.71,"preClose":34.6893,"latestTime":"19:30 EDT","volume":16,"amount":555.1565,"timestamp":1789774205753,"change":0.0207,"changeRate":0.000597,"amplitude":0},"volumeRatio":1.1394951737825971,"impliedVol":0.0457,"impliedVolPercentile":0.0199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1394951737825971,"shares":2780001,"dividePrice":0.2569,"high":35.13,"amplitude":0.014246,"preClose":35.1258,"low":34.6296,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.6893,"eps":0,"divideRate":0.007406,"volume":25488,"delay":0,"ttmEps":0,"open":35.13,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.472,"twentyDayClose":35.8,"sixtyDayClose":31.2119},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1154236776","title":"Sichuan Biokin's Subsidiary to Invest $5 Million in Oncology Drug Developer Connexus Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1154236776","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154236776?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:56","pubTimestamp":1789646181,"startTime":"0","endTime":"0","summary":"Sichuan Biokin Pharmaceutical Co., Ltd. (688506.SH) has announced that its wholly-owned subsidiary, Pangu Capital, plans to subscribe for 3.881 million Series A preferred shares of Connexus...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","159992","91194","LENZ","BK4007","BK1161","IBBQ","BK1574","LNGR","BK4139","MEDX","06978","BK0239","688506"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147246752","title":"Fed Rate Decision Finalized, A-Share Market Sees Light Volume Retreat, Grain and Innovative Drug Sectors Gain Momentum | 3A Daily Briefing (September 17, 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=1147246752","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147246752?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:11","pubTimestamp":1789643512,"startTime":"0","endTime":"0","summary":"The Federal Reserve's long-awaited rate hike has officially landed, injecting a wave of certainty into global markets. In response, China's A-share market experienced a modest pullback with reduced...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07233","BK1147","03188","06978","IBBQ","399300","159992","BK1574","PTMC","02827","03130","83130","83188","EQRR","02846","MEDX","82846","LNGR","BK1161","159982","159073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961345","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961345?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:10","pubTimestamp":1789643407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Atricure (ATRC) and Stryker (SYK) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GB00B4QBRK32.GBP","BK4588","XBI","ATRC","BBH","PBE","IBB","LU0690374615.EUR","LU0882574055.USD","XLV","LU0823417653.USD","AMGN","BK4566","LU2362540622.SGD","LU1061106388.HKD","LU2506951875.HKD","LU0109394709.USD","BK4585","BK4581","LU0432979614.USD","TBXU","LU0029874061.USD","GB00B4LPDJ14.GBP","BK4082","PJP","LU2362541513.USD","HCSG","LU2242652126.USD","LU2089984988.USD","LU2324357040.USD","LU0128526141.USD","BIB","LU2362541273.HKD","LU0528227936.USD","LU0868494617.USD","LABU","LU2468319806.SGD","SYK","BK4534","IBBQ","LU0058720904.USD","IHI","IE00BJT1NW94.SGD","BK4599","LU1571399168.USD","LU2404859741.USD","LU2506952097.USD","LU2404859667.USD","LU0690374961.EUR","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COPJ","CPXR","BIB","LU2324357040.USD","QCmain","LU1035775433.USD","GNMX","IE0002270589.USD","LU1430594728.SGD","LU1093756168.USD","LU2089984988.USD","LU2468319806.SGD","IE00B19Z9P08.USD","IBBQ","LU2362541513.USD","LU2417539215.USD","LU0823416689.USD","IE00B894F039.SGD","MHGmain","LU2236285917.USD","IE00B19Z9Z06.USD","LU1778281490.HKD","ICOP","LU0320765992.SGD","IE0009355771.USD","SG9999013999.USD","UYM","LU0889565916.HKD","CPER","VRTX","BK4139","LU2237438978.USD","PBE","LU0566484027.USD","XME","LU1069344957.HKD","IE00BFTCPJ56.SGD","BK4023","COPP","BK4532","LU0432979614.USD","TBXU","LU2462157665.USD","IBB","BBH","IE00B2B36J28.USD","VERX","IDNA","LU1093756325.SGD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143711800","title":"ETF Market Wrap (09.17) - Fed Hawkish Stance Weighs on Sentiment; AI Drug Development Bolsters Pharma Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1143711800","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143711800?lang=en_us&edition=fundamental","pubTime":"2026-09-17 16:45","pubTimestamp":1789634750,"startTime":"0","endTime":"0","summary":"Hong Kong stocks opened sharply lower on Tuesday but gradually pared losses as a hawkish Federal Reserve rate hike dampened risk appetite. Tech, precious metals, and oil stocks weakened, while...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIHY","BK4535","IEF","BK4588","FPX","HMOP","WAMA","HAWG","SSO","MINT","01477","AGG","DDFM","SFY","UPSD","HYG","ARTY","BK4561","DBND","NEMD","FTLS","EBUF","NSCS","EDV","ISHG","SPDN","XSMO","SH","TSYW","SKRE","TBJL","VGIT","RSEE","MUNX","BBSB","ZBmain","ROMO","SPHY","BND","MMAX","VFH","SPUU","159992","CBOX","LQD","SPYU","SPYI","BK1191","IEI","BK4550","SPXL","TLTW","BBLB","VGLT","VTHR","LIAJ","BSV","UDN","AESR","HYGU","VBK","BK4585","BK4504","JSMD","QTOC","06978","MESmain","SPYH","FEM","BBIB","BK1161","TFJL","DMAX","GTOQ","VCHY","YSPY","VGSH","IAT","LQDD","HYGD","SPYM","DRKY","SCHO","TLT","TPUT","ZTmain","TYO","GXDW","UUP","HYP","GOLY","TOS","MYCN","SPXU","MFSG","NELS","SPYB","CHAT","SPYQ","BK1574","SGOV","SDS","VFMO","IBBQ","MOOD","FDN","BK4534","BWX","MSTB","NGHT","SPY","VOO","SMAX","SPHB","OOQB","AGIX","BK4559","DPST","MUB","KBWB","UBmain","CIVG","OEF","EMPB","AIPO","XBIL","UBT","JULD","LQDU","PBDC","PTMC","HIBL","IGOV","ESmain","KRE","SHY","BCSM","TIP","TBIL","ISSB","JPST","VCIT","IVV","SPXS","TLTI","TMF","USHY","ZFmain","BWZ","GOVT","FAZ","GBIL","VEXC","TLH","SHV","TBT","BOXX","RAUS","FXA","TLTX","VCSH","UPRO","MEDX","BBB","ZROZ","SCYB","TMFX","HYLB","FLGV","EIM","OEX","KRX","IWO","FITZ","BK4581","XLF","03069","BIL",".SPX","XLRI","BOND","KBE","TNmain","APRJ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101924698","title":"Big Pharma's AI Push Triggers Rally Across A-Shares and CRO Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1101924698","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101924698?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:28","pubTimestamp":1789626503,"startTime":"0","endTime":"0","summary":"A fresh wave of industry collaboration is emerging around AI-driven drug development, sparking a broad re-rating of upstream service providers. On September 16, Novo Nordisk announced a partnership...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03130","QTOC","02827","159992","07233","02846","VTHR","83130","ARTY","AGIX","BGIA","03188","LNGR","BK1191","83188","CHAT","01477","IBBQ","MEDX","AIPO","06978","82846","BK1574","BK1161","399300","159982","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100386320","title":"Mid-Year Drug Sector Report Shows Growing Momentum, Analysts Back Innovative Therapies and Supply Chain Players","url":"https://stock-news.laohu8.com/highlight/detail?id=1100386320","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100386320?lang=en_us&edition=fundamental","pubTime":"2026-09-17 10:58","pubTimestamp":1789613900,"startTime":"0","endTime":"0","summary":" In the first half of 2026, the pharmaceutical industry's fundamentals continued to strengthen, with profit growth significantly outpacing revenue gains, according to a new research note. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","159992","BK0188","BK1574","MEDX","09939","BK0183","BK0028","BK1161","IBBQ","BK0276","06978","002736","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936994","title":"Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936994","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936994?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:35","pubTimestamp":1789594520,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced topline results from ELPIS II, its Phase 2b clinical trial evaluating its investigational stem cell therapy laromestroc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GNOM","IDNA","SYNB","MEDX","LGVN","HYLG","NVIB","GDOC","FBT","IBBQ","LFSC","TBXU","BK4585","IBB","CNCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593306","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593306","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593306?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:28","pubTimestamp":1789590524,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stockGilead: Chief Comm & Corp Aff Officer Johanna Mercier sold 3,000 common shares on Sep. 15, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6sfPNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4568","BMED","IE00B3T34201.USD","LU0859254822.USD","LU2089984988.USD","TBXU","IE00B19Z3581.USD","LU0289739699.SGD","LU0122379950.USD","IBBQ","GILD","BBH","LU0109394709.USD","BK4585","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU0320765992.SGD","LU0965509283.SGD","LU1023059063.AUD","LU2468319806.SGD","SG9999015952.SGD","LU0882574055.USD","IE00BKVL7J92.USD","LU0965509101.SGD","LU2087621335.USD","LU0114720955.EUR","BK4550","LU0823416689.USD","BK4578","LU1430594728.SGD","MEDI","TMED","LU1778281490.HKD","LU1066053197.SGD","IE0002270589.USD","LU1674673691.USD","IBB","SG9999015986.USD","LU1674673428.USD","BIB","LU1066051498.USD","BK4566","IE00B19Z3B42.SGD","LU1057294990.SGD","SG9999015945.SGD","LU2357627491.SGD","LU1585245621.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983112","title":"Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983112?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:30","pubTimestamp":1789561801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA4XXCG2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","BBH","LU2089984988.USD","LU1585245621.USD","LU0823416689.USD","BMED","LU0965509010.AUD","LU1057294990.SGD","LU0965509283.SGD","BK4566","LU0234570918.USD","LU1934455863.HKD","LU2357627491.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU1839511570.USD","IE00BKVL7J92.USD","IBB","LU1066053197.SGD","LU1061106388.HKD","IE00B7SZLL34.SGD","BIB","LU0882574055.USD","LU1571399168.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","LU1023059063.AUD","SG9999015945.SGD","TMED","LU1430594728.SGD","SG9999015952.SGD","LU1037948541.HKD","LU0965509101.SGD","LU1037948897.HKD","LU0859254822.USD","BK4568","LU2324357040.USD","LU0109394709.USD","LU1934455277.USD","SG9999015978.USD","LU0122379950.USD","LU0861579265.USD","IE00B19Z3581.USD","LU2087621335.USD","IBBQ","MEDI","GILD","BK4550","LU2112291526.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164610791","title":"Shanghai Raas Advances SR604 Injection Into Phase III Clinical Trial for Hemophilia Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=1164610791","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164610791?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:58","pubTimestamp":1789559898,"startTime":"0","endTime":"0","summary":"Shanghai Raas Blood Products Co.,Ltd. (002252.SZ) has announced that its investigational drug, SR604 Injection, has been listed on the National Medical Products Administration's drug clinical trial...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","MDTX","BMED","BK0196","BK0188","PSYK","IBBJ","002252","BK0028","BK0239","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667979600","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667979600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667979600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","XBI","LU0889565916.HKD","SGXZ57979304.SGD","IBBQ","LU0757428866.USD","LU2237438978.USD","LU1093756325.SGD","LU1674673428.USD","BIB","LU1035775433.USD","IE00BJJMRZ35.SGD","BK4588","LU0109394709.USD","BK4581","HCSG","LU0061475181.USD","LU0289739699.SGD","LU1069344957.HKD","LU1093756168.USD","LU2324357040.USD","LU2362540622.SGD","LU2362541273.HKD","BBH","BK4533","XLV","GNMX","LABU","VRTX","LU2417539215.USD","LU2462157665.USD","IE00B894F039.SGD","VERX","BK4023","CRL","LU0390134368.USD","LU1778281490.HKD","LU1559883803.SGD","LU1430594728.SGD","MEDI","LU2236285917.USD","IDNA","LU1585245621.USD","BK4585","PBE","IBB","IE00BZ9MQY76.HKD","LU0029874061.USD","ASND","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600950","title":"The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600950?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557600,"startTime":"0","endTime":"0","summary":"T. Rowe Price manager looks for trouble to find his global value betsT.Rowe Price manager Sebastien Mallet is betting on more than technology for his five-star fund.One secret to global value manager Sebastien Mallet's success?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","IE0009356076.USD","LU0823397103.USD","BK4561","IE00BLSP4239.USD","LU0792757196.USD","LU1037948897.HKD","LU1988902786.USD","IE00BJTD4V19.USD","ARTY","LU1236620750.USD","LU1629891620.HKD","IE00BQXX3D17.EUR","BK4532","LU0823411888.USD","07709","BK4135","SKHU","LU2324357040.USD","CHPS","LU1861559042.SGD","LU1934455277.USD","AMDL","LU0823434583.USD","BK4534","LU0225283273.USD","IE00B3S45H60.SGD","LU0097036916.USD","LU2756315664.SGD","BK4548","SGXZ23171101.USD","LU1585245621.USD","SGXZ99366536.SGD","04335","DAMD","LU0154236417.USD","LU2213496289.HKD","LU0170899867.USD","LU2237443895.HKD","CHAT","BBH","BK4141","LU2237957902.USD","LU0889565916.HKD","LU0211326839.USD","LU1861215975.USD","BK4543","LU2381873111.SGD","LU2552382215.SGD","SKHL","SMH","LU2008162690.USD","LU1261432733.SGD","LU1548497426.USD","LU1880398554.USD","BK4550","HK0000304805.HKD","IE00BJTD4N35.SGD","IE00BZ1G4Q59.USD","IE00BQXX3F31.USD","IE00BSNM7G36.USD","IE00BKDWB100.SGD","LU0048584097.USD","LU2750360997.AUD","LU2764263203.CNY","IE00B5949003.HKD","LU0029864427.USD","IE00BJLML261.HKD","LU2168564495.EUR","LU1989772923.USD","LU1852331112.SGD","WUGI","SGXZ81514606.USD","LU0353189680.USD","PSI","LU0979878070.USD","LU0683600562.USD","GOAU","LU1363072403.SGD","LU0310800379.SGD","LU0868494617.USD","LU0323591593.USD","QQQA","XLF","HK0000304797.USD","AMDU","BMED","LU0109392836.USD","LU1430594728.SGD","LU1829250122.USD","IBB","LU2543165471.USD","GDX","IE00B1BXHZ80.USD","LU2265009873.SGD","LU0174119429.USD","FNCL","SKDD","LU1989772840.SGD","SLVR","LU1668664300.SGD","LU0114720955.EUR","GLDN","LU0208291251.USD","SKHA","VFH","LU1267930573.SGD","LU2168563687.JPY","IE00BDRTCR15.USD","LU2097829019.USD","BK4568","IE0004445239.USD","LU2089985449.USD","LU2023250843.SGD","SGXZ51526630.SGD","IE00B1XK9C88.USD","SKHZ","BK4512","LU0882574055.USD","LU1804176565.USD","LU1084165304.USD","LU0965508806.USD","LU0612318971.USD","LU1066053197.SGD","LU1989764748.USD","LU0612318385.USD","LU1145028129.USD","LU0321505868.SGD","BK4575","LU1244550577.SGD","SKHN","SG9999001424.SGD","IE00B3T34201.USD","BK4583","LU1280957306.USD","LU2430703251.USD","LU1232071149.USD","LU1551013342.USD","FAI","LU2168564065.EUR","LU2471134796.USD","SG9999015952.SGD","LU0965509010.AUD","LU0417517546.SGD","LU0210536198.USD","LU0211331839.USD","LU1032466523.USD","LU0081259029.USD","LU2592432038.USD","BK4017","BK4614","LU0345774631.USD","BK4007","SK","BK4504","LU0082616367.USD","LU2355687059.USD","IE00BFXG1179.USD","LU1043141396.HKD","LU1061106388.HKD","INTC","LU0106261372.USD","SKHX","LU1670628061.USD","LU2750360641.GBP","LU0256863811.USD","CNAV","LU2237443382.USD","BK4142","LU0965509283.SGD","LU0320765992.SGD","LU0149725797.USD","LU0823416689.USD","LU2746668461.USD","LU1720051108.HKD","LU0321505439.SGD","LU0058720904.USD","LU1316542783.SGD","LU1861220033.SGD","LU0265550946.USD","LU0251142724.SGD","LU2462157665.USD","TRFK","AMDG","LU1934455863.HKD","XNTK","LU2552382058.USD","AMDC","IETC","LU0127658192.USD","LU1150488135.SGD","LU0122379950.USD","LU2087621335.USD","BK4515","FTXL","IE00BK4W5L77.USD","LU0203347892.USD","LU1496350171.SGD","SKHQ","LU0345769128.USD","FNV","LU0820561818.USD","WISE","LU1303367103.USD","LU0994945656.USD","LU0215105999.USD","AMDW","SG9999002232.USD","LU1267930490.SGD","MEDI","LU0787776722.HKD","LU0882574139.USD","LU0823421333.USD","LU2860962120.EUR","LU0353189763.USD","LU0708994859.HKD","LU1674673428.USD","BK4529","AMDY","SG9999004303.SGD","BK4579","LU0256863902.USD","LU1057294990.SGD","LU2023250330.USD","LU2361044865.SGD","LU2089984988.USD","LU0964807845.USD","LU0965509101.SGD","LU1037948541.HKD","LU1778281490.HKD","LU2112291526.USD","ILDR","IE000F7OJYX1.SGD","LU1674673691.USD","LU2360106780.USD","LU1989764664.SGD","LU0390134368.USD","LU0006306889.USD","LU0654597011.USD","LU2148611432.USD","LU0289739699.SGD","AMDS","IE00BHPRN162.USD","LU0320765489.SGD","LU1043141123.HKD","BK4573","LU0889566641.SGD","LU0187121727.USD","LU0496365809.HKD","BKNU","LU0426417589.USD","LU1116320901.HKD","IE00B19Z3B42.SGD","IBBQ","IE00BLSP4452.SGD","LU0238689110.USD","BKNG","BK4207","SMHX","AIS","LU2471134523.USD","INT","SAMD0main","LU2896262040.SGD","BK4612","LU0823434740.USD","LU0320765646.SGD","LU2290526834.HKD","LU0056508442.USD","LU1162221912.USD","SG9999015978.USD","LU0861579265.USD","LU2106854487.HKD","LU0070302665.USD","LU2244417387.USD","IE00BWXC8680.SGD","LU1974910355.USD","IE00BDCRKT87.USD","LU2746668974.SGD","IE00BQXX3C00.GBP","INYY","LU0211328371.USD","WPM","LU0823413660.USD","LU1244550221.USD","LU2357627491.SGD","DRIV","LU2505996509.AUD","IXG","BAI","LU1861558580.USD","LU0820562030.AUD","LU2236285917.USD","LU2468319806.SGD","FMTL","BK4554","LU2361044949.HKD","SINTCmain","LU0426412945.USD","LU0234570918.USD","INTW","JPMO","LU2458330243.SGD","IE00BYXW3230.USD","LU0157215616.USD","BK4232","LU1923623000.USD","LU2505996681.GBP","TEK","LU0234572021.USD","LU0345774391.USD","BK4602","LU0345769631.USD","LU0265550359.USD","IE00B775SV38.USD","IE000M9KFDE8.USD","IE0034235188.USD","IE00BMPRXR70.SGD","BK4567","TMED","LU2108987350.USD","AMYY","LU2242649171.HKD","LU2764263039.SGD","BK4520","LU1956131251.USD","LU2462591350.SGD","LU2247934214.USD","IE0034235295.USD","LU2250418816.HKD","LU1934455194.USD","AUAU","LU2430703095.HKD","LU1951200564.SGD","IE000MB6IJN5.SGD","BK4605","LU1366192091.USD","LU1917777945.USD","WNDR","TROW","SILJ","IYF","IE0001KFT4U8.USD","LU0786609619.USD","LU0719512351.SGD","LU0943347566.SGD","LU1839511570.USD","LU1116320737.USD","LU2720916845.USD","LU0942090050.USD","LU0274383776.USD","LU1244550494.USD","LU0077335932.USD","LU2357305700.SGD","LU0211326755.USD","AMDD","USXF","LU1571399168.USD","AIQ","LU0640476718.USD","SOXX","LU2237443549.SGD","LU1121112475.USD","LU0971096721.USD","LU2168564222.USD","LU1894683348.USD","HYNX","LU2177674079.SGD","LU1236620834.HKD","BK4535","IE00B5TLWC47.USD","LU1064131342.USD","LU1951198990.SGD","SIL","LU2211815571.USD","LU2054465674.USD","LU0266013472.USD","IE00BMPRXN33.USD","BK4581","LU0689472784.USD","LU0432979614.USD","LU0198837287.USD","LU2417539215.USD","LU0251131958.USD","LU2471134879.HKD","LU1023059063.AUD","SG9999001440.SGD","LU0211327993.USD","BK4516","LU0823421416.USD","UYG","LU1242518857.USD","LU1803068979.SGD","BK4022","LU2264538146.SGD","IYG","LU0106831901.USD","AMD","LU1880398471.USD","IE0034235303.USD","JPM","LU0642271901.SGD","AMUU","SG9999015986.USD","TTEQ","LU2023250504.SGD","IE00BKVL7J92.USD","LU1914381329.SGD","LU0203345920.USD","AZNH","SG9999015945.SGD","LU1894683264.USD","IE000BZT7R73.USD","SG9999002224.SGD","LU1670627923.USD","LINT","BK4585","BK4139","LU0133085943.USD","LU2087625088.SGD","LU1366333091.USD","LU1242518931.SGD","TRUF","LU0109394709.USD","LU2361045086.USD","IE00BN8TJ469.HKD","LU2098885051.SGD","GAMR","LU0823413587.USD","IE000SO60NU8.SGD","IE0000B7K699.USD","IE00BMPRXQ63.HKD","IE00BK4W5M84.HKD","KBWB","LU0316494557.USD","LU1066051498.USD","LU1119994496.HKD","IE000WAW04H5.SGD","BK4527","LU0557290698.USD","LEGR","LU0976567544.SGD","LU0742534661.SGD","LU0310799852.SGD","BK4566","JPO","LU2430703178.SGD","BK4588","LU2237443978.SGD","FTXO","LU2168564149.EUR","LU0823397285.USD","LU2764262908.HKD","LU1699723380.USD","LU2471134952.CNY","LU2360107168.USD","IE00B7SZLL34.SGD","LU0345770993.USD","LU1150488218.USD","LU2461242641.AUD","GILD","TFNS","SKHYV","SKUU","LU0820561909.HKD","LU0128525929.USD","LU0859254822.USD","LU0251132253.USD","LU1720051017.SGD","IE0002270589.USD","LU1496350502.SGD","LU2756315318.SGD","TBXU","LU1551013425.SGD","LU2237443465.HKD","IE00B19Z3581.USD","LU0267386448.USD","LU0889565833.HKD","AWAY","LU0048573561.USD","BIB","SKHY","LU1430597077.USD","LU2237443622.USD","LU2931357623.SGD","JBHT","SOXY","IE00BBT3K403.USD","BK4533","LU2456880835.USD","LU0345770308.USD","BK4578","LU0868494708.USD","LU1267930813.SGD","LU2237957811.SGD","LU2552382132.HKD","LU2458330169.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607925","title":"Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607925?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":"Sling Therapeutics raises $123 million to advance thyroid eye disease drugSept 16 (Reuters)-Drug developer Sling Therapeutics said on Wednesday ithad raised $123 million to advance a late-stage trial ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N457178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE00BJT1NW94.SGD","LU1571399168.USD","LU0868494617.USD","BK4139","IBBQ","BK4599","PBE","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU2242652126.USD","BK4585","LU0320765992.SGD","LU2112291526.USD","IE0009355771.USD","LU0122379950.USD","BK4534","LU1061106388.HKD","LU2468319806.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU0289739699.SGD","TBXU","BK4581","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4566","IE0002141913.USD","LU0058720904.USD","LU1023059063.AUD","BK4588","LU1983299246.USD","LU2242646821.SGD","BIB","AMGN","IE00BJJMRZ35.SGD","VRDN","LU2089984988.USD","BK4533","SG9999001440.SGD","BBH","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150087334","title":"CSPC Pharma Initiates Phase II Clinical Trial of SYH2069 Injection for Type 2 Diabetes at First Chinese Study Center","url":"https://stock-news.laohu8.com/highlight/detail?id=1150087334","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150087334?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:40","pubTimestamp":1789555245,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) announced that the Phase II clinical trial for its SYH2069 injection, intended to treat adults with type 2 diabetes, has formally commenced at the first study center in China.The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0067412154.USD","LU1993786604.SGD","IBBQ","LU1152091168.USD","IBBJ","LU1008478684.HKD","MDTX","LU1226287875.USD","IE00B5MMRT66.SGD","LU1960683339.HKD","LU0880133367.SGD","LU1226288253.USD","IE00BZ08YR35.GBP","LU0072913022.USD","PSYK","LU1226287792.SGD","KURE","IE00BZ08YT58.USD","LU1152091754.HKD","LU0315179316.USD","LU1226288170.HKD","LU0326950275.SGD","IE0008369823.USD","IE00B543WZ88.USD","LU1226287529.USD","01093","BK1191","LU0501845795.SGD","LU1951186391.HKD","LU0140636845.USD","LU2039709279.SGD","SG9999004220.SGD","HK0000165453.HKD","IE00B031HY20.USD","LU1807302812.USD","LU1813983027.USD","LU1328277881.USD","BK1515","IE0008368742.USD","LU0314109678.HKD","BMED","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106853030","title":"Beijing Sun-Novo Secures Clinical Trial Approval for Heart Failure Treatment Candidate BTP0427","url":"https://stock-news.laohu8.com/highlight/detail?id=1106853030","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106853030?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:38","pubTimestamp":1789551493,"startTime":"0","endTime":"0","summary":"Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. (688621.SH) has announced that it, together with its wholly-owned subsidiary Jiangsu Novobita New Drug Research and Development Co., Ltd., has...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","688621","BK0216","IBBQ","PSYK","BMED","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182838283","title":"ST Bailing's Subsidiary Receives Clinical Trial Approval for Tangning Tongluo Cream","url":"https://stock-news.laohu8.com/highlight/detail?id=1182838283","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182838283?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:05","pubTimestamp":1789549523,"startTime":"0","endTime":"0","summary":"Guizhou Bailing Group Pharmaceutical Co.,Ltd. (002424.SZ) has announced that its wholly-owned subsidiary, Bailing Yuxiu (Zhuhai) Pharmaceutical Co., Ltd., has received the Drug Clinical Trial...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","002424","PSYK","BK0183","BK0146","IBBJ","IBBQ","BK0077","MDTX","BK0188","BMED","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177370867","title":"Hong Kong Stock Market Update: Hengrui Pharma Surges Nearly 4% in Late Trading Following Dual Clinical Trial Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1177370867","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177370867?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:52","pubTimestamp":1789545137,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) saw its shares climb nearly 4% during the final stretch of Thursday's trading session, buoyed by regulatory approvals for two distinct clinical programs targeting separate...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1064130708.USD","LU1255011170.USD","IBBJ","LU1969619763.USD","LU1328615791.USD","MDTX","LU2580892789.USD","LU0405327148.USD","LU2097828714.EUR","600276","LU0405327494.USD","LU2289578879.USD","KCAI","LU2495084118.USD","LU1781817850.SGD","BK0183","BK4585","LU1997244956.HKD","BK0188","LU1023057109.AUD","BK0196","PSYK","LU2328871848.SGD","BK0060","LU1997245177.USD","LU2097828631.EUR","LU2097828557.USD","LU1820825898.SGD","LU1580142542.USD","LU2580892862.HKD","LU1146622755.USD","LU1655091616.SGD","BK0239","BK1191","LU2488822045.USD","LU2097828474.EUR","BK4588","BMED","LU1997245094.SGD","LU0359201612.USD","VXUS","LU2097828805.USD","LU0359201885.HKD","BK0028","01276","LU0359202008.SGD","BK0012","LU2148510915.USD","LU1064131003.USD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160591234","title":"Hong Kong Policy Address: Northern Metropolis Accelerates with Mainland Partnerships and Clinical Trial Hub Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1160591234","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160591234?lang=en_us&edition=fundamental","pubTime":"2026-09-16 13:10","pubTimestamp":1789535419,"startTime":"0","endTime":"0","summary":"Hong Kong Chief Executive John Lee announced in today's policy address that the Northern Metropolis development is transitioning from blueprint to tangible implementation, with the three university...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","159983","MDTX","BMED","IBBQ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU0823416689.USD","LU1066053197.SGD","MEDI","LU2112291526.USD","LU1066051498.USD","IBBQ","IE00BKVL7J92.USD","LU0114720955.EUR","LU1674673691.USD","LU1430594728.SGD","BIB","BK4578","LU0889565916.HKD","LU0965509283.SGD","LU1934455277.USD","LU2087621335.USD","BK4550","BBH","LU0058720904.USD","LU1037948541.HKD","LU1057294990.SGD","LU1839511570.USD","LU2089984988.USD","LU2468319806.SGD","LU2357627491.SGD","LU1585245621.USD","BK4532","LU1061106388.HKD","LU0289739699.SGD","BMED","TMED","IE00B7SZLL34.SGD","LU1037948897.HKD","LU1934455863.HKD","LU0861579265.USD","GILD","SG9999015978.USD","IBB","TBXU","IE00BZ1G4Q59.USD","SG9999015986.USD","LU0234570918.USD","LU1934455194.USD","LU0320765992.SGD","LU0965509010.AUD","BK4583","LU1778281490.HKD","SG9999015945.SGD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}